StockDrifts LogoStockDrifts

Seizert Capital Partners 13F Portfolio

Portfolio Manager
Seizert Capital Partners LLC
Performance
+11.18% (2026 Q2)
AUM (13F)
$2.42B
# of Holdings
181
Performance Rank
Allocation (Top 20)
50.27%
Latest filing
Q2 2026

Seizert Capital Partners LLC Holdings Map

Top 50 Seizert Capital Partners LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
MTCH
Match Group Inc
3.29%2.10M$79.8M
-0.57%(-12.02K)
2025-Q2: 1.77M shares2025-Q3: 1.77M shares2025-Q4: 1.77M shares2026-Q1: 2.11M shares2026-Q2: 2.10M shares
$33.94(+11.81%)
2026-06-30
NTAP
NetApp Inc.
3.06%479.7K$74.2M
-2.71%(-13.38K)
2025-Q2: 521.5K shares2025-Q3: 508.2K shares2025-Q4: 505.6K shares2026-Q1: 493.1K shares2026-Q2: 479.7K shares
$92.23(+124.53%)
2026-06-30
JPM
JPMorgan Chase & Co.
2.93%216.9K$71.0M
-3.57%(-8.02K)
2025-Q2: 279.1K shares2025-Q3: 239.6K shares2025-Q4: 233.9K shares2026-Q1: 224.9K shares2026-Q2: 216.9K shares
$75.44(+383.46%)
2026-06-30
CSCO
Cisco Systems, Inc.
2.9%597.6K$70.2M
-4.22%(-26.35K)
2025-Q2: 682.0K shares2025-Q3: 661.8K shares2025-Q4: 647.2K shares2026-Q1: 623.9K shares2026-Q2: 597.6K shares
$35.10(+223.47%)
2026-06-30
QCOM
QUALCOMM Inc.
2.74%359.6K$66.4M
-17.82%(-78.00K)
2025-Q2: 366.1K shares2025-Q3: 454.6K shares2025-Q4: 446.3K shares2026-Q1: 437.6K shares2026-Q2: 359.6K shares
$153.83(+5.43%)
2026-06-30
GS
Goldman Sachs Group, Inc.
2.73%65.5K$66.2M
-3.53%(-2.39K)
2025-Q2: 101.7K shares2025-Q3: 99.7K shares2025-Q4: 97.9K shares2026-Q1: 67.9K shares2026-Q2: 65.5K shares
$229.88(+355.62%)
2026-06-30
BRK.B
Berkshire Hathaway Inc.
2.61%126.5K$63.3M
+20.74%(+21.73K)
2025-Q2: 112.3K shares2025-Q3: 110.6K shares2025-Q4: 108.7K shares2026-Q1: 104.8K shares2026-Q2: 126.5K shares
$195.04(+157.05%)
2026-06-30
EXPE
Expedia Group Inc
2.61%246.6K$63.1M
-4.03%(-10.36K)
2025-Q2: 250.5K shares2025-Q3: 277.6K shares2025-Q4: 222.6K shares2026-Q1: 257.0K shares2026-Q2: 246.6K shares
$142.61(+129.70%)
2026-06-30
SNA
Snap-On Incorporated
2.5%150.6K$60.6M
+40.62%(+43.51K)
2025-Q2: 14.4K shares2025-Q3: 13.8K shares2025-Q4: 13.8K shares2026-Q1: 107.1K shares2026-Q2: 150.6K shares
$355.37(+13.56%)
2026-06-30
GNTX
Gentex Corp
2.44%2.34M$59.0M
+17.46%(+347.24K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 267.9K shares2026-Q1: 1.99M shares2026-Q2: 2.34M shares
$23.05(+3.19%)
2026-06-30

About Seizert Capital Partners LLCโ€™s portfolio

Seizert Capital Partners LLC reports $2.42B in US-listed equity holdings across 181 positions in its most recent 13F filing. Its largest disclosed positions are MTCH (3.3%), NTAP (3.1%) and JPM (2.9%). The top 20 holdings account for 50.27% of reported assets. Its disclosed equity book has returned +50.54% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
MTCH โ€” 3.9% ($79.75M)NTAP โ€” 3.6% ($74.25M)JPM โ€” 3.4% ($70.99M)CSCO โ€” 3.4% ($70.19M)QCOM โ€” 3.2% ($66.45M)GS โ€” 3.2% ($66.24M)BRK.B โ€” 3.1% ($63.29M)EXPE โ€” 3.1% ($63.11M)SNA โ€” 2.9% ($60.61M)GNTX โ€” 2.9% ($59.03M)Other โ€” 67.4% ($1.39B)
33%in top 10
  • MTCH3.9%
  • NTAP3.6%
  • JPM3.4%
  • CSCO3.4%
  • QCOM3.2%
  • GS3.2%
  • BRK.B3.1%
  • EXPE3.1%
  • SNA2.9%
  • GNTX2.9%
  • Other67.4%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

Added to
22
METAMeta Platforms Inc+268.4%
NBIXNeurocrine Biosciences Inc+216.4%
PHMPulte Group Inc+51.0%
SNASnap-On Incorporated+40.6%
+18 more
Trimmed
28
UTHRUnited Therapeutics Corporation-26.6%
QCOMQUALCOMM Inc.-17.8%
REGNRegeneron Pharmaceuticals, Inc.-16.9%
UNHUnitedHealth Group Inc.-15.7%
+24 more

Unlock alerts, watchlists & AI chat

Sign up free to track Seizert Capital Partners LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Seizert Capital Partners LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1134283). View Seizert Capital Partners LLCโ€™s 13F filings on SEC

More 13F analyses

View all